23andMe Holding Co. (ME)

Last Closing Price: 2.05 (2023-06-02)

Company Description

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition Corp., is headquartered in Sunnyvale, CA.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $299.49M
Net Income (Most Recent Fiscal Year) $-311.66M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 3.16
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 1.32
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) -104.99%
Net Margin (Trailing 12 Months) -104.06%
Return on Equity (Trailing 12 Months) -39.72%
Return on Assets (Trailing 12 Months) -30.63%
Current Ratio (Most Recent Fiscal Quarter) 2.84
Quick Ratio (Most Recent Fiscal Quarter) 2.78
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 13.90
Book Value per Share (Most Recent Fiscal Quarter) $1.55
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-0.69
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Common Shares Outstanding 461.26M
Free Float 328.32M
Market Capitalization $945.57M
Average Volume (Last 20 Days) 2.55M
Beta (Past 60 Months) 1.37
Percentage Held By Insiders (Latest Annual Proxy Report) 28.82%
Percentage Held By Institutions (Latest 13F Reports) 29.49%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%